HopeTABergslandEKBozkurtMF, et al.Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J Nucl Med. 2018;59(1):66-74. doi:10.2967/jnumed.117.202275
3.
HalfdanarsonTRStrosbergJRTangL, et al.The North American neuroendocrine tumor society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(7):863-881. doi:10.1097/MPA.0000000000001597
4.
BarrioMCzerninJFantiS, et al.The impact of somatostatin receptor-directed PET/CT on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med. 2017;58(5):756-761. doi:10.2967/jnumed.116.185587